Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza
Alexander E. Merkler(Weill Cornell Medicine), Babak B. Navi(Memorial Sloan Kettering Cancer Center), Santosh B. Murthy(MIND Research Institute), Joshua Lantos(Weill Cornell Medicine), Parag Goyal(Cornell University), Alan Z. Segal(Cornell University), Philip E. Stieg(Brigham and Women's Hospital), Ajay Gupta(Cornell University), Thomas R. Campion(Cornell University), Hooman Kamel(Cornell University), Kelsey N. Lansdale(Weill Cornell Medicine), Marika Cusick(Weill Cornell Medicine), Samuel S. Bruce(MIND Research Institute), Saad Mir(MIND Research Institute), Natalie M. LeMoss(Cornell University), Cenai Zhang(Weill Cornell Medicine), Eaton Lin(Weill Cornell Medicine), Iván Díaz(Cornell University), Neal S. Parikh(Cornell University), Matthew E. Fink(Weill Cornell Medicine), Joshua Kahan(Cornell University), Edward J. Schenck(Cornell University), Costantino Iadecola(Weill Cornell Medicine)
Cited by 928
Related Papers
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Inflammation and Stroke: An Overview
|Neurotherapeutics|2016|951